Filing Flows › 8-K events › Innovative Industrial Properties
Innovative Industrial Properties: entry into a material definitive agreement
Form 8-K filed Oct 27, 2026 · items 1.01, 2.03
What the filing says
On October 21, 2026, Innovative Industrial Properties, Inc. (the “Company”), through its operating partnership, IIP Operating Partnership, LP (“IIP OP”), entered into Amendment Number Six to Loan Agreement (the “Sixth Amendment”), by and among IIP OP, as borrower, East West Bank, as agent (in such capacity, the “Agent”
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 2.03: 0.0% next session across 13,268. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
Item 2.03 — Creation of a direct financial obligation. New debt or a guarantee: the amount, the rate and the maturity set the cost of capital and the repayment wall ahead.
Innovative Industrial Properties at a glance
Innovative Industrial Properties, Q3 2026: revenue $64.9M (+0.4% year over year), operating margin 45.3%. The chart follows the revenue to costs, profit and cash.
Innovative Industrial Properties: every quarter, Q/Q and Y/Y, holders and guidance →
Innovative Industrial Properties’s other material 8-Ks
- Nov 2, 2026 — Mergers and acquisitions Innovative Industrial Properties Reports Third Quarter 2026 Results
Other recent debt and financing
- Airsculpt Technologies Nov 6, 2026
- Starry Sea Acquisition Nov 6, 2026
- Repligen Nov 6, 2026
- Evertec Nov 6, 2026
- Clean Energy Technologies Nov 6, 2026
- Reed's Nov 6, 2026
- Protagenic Therapeutics, Inc.\new Nov 6, 2026
- CNL Strategic Residential Credit Nov 6, 2026
- Health In Tech Nov 6, 2026
- Profusa Nov 6, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.